BusinessINC Research Schedules First Quarter 2016 Earnings Call for Monday, May 2, 2016By Nasdaq OMXApr 18, 2016, 4:37 PM UTC
BusinessFibrocell and Intrexon Announce Allowance to Commence Phase I/II Trial for FCX-007 for the Treatment of Recessive Dystrophic Epidermolysis Bullosa (RDEB)By Nasdaq OMXApr 18, 2016, 12:00 PM UTC
Businessathenahealth Partners with Intacct to Better Serve Financial Needs of HospitalsBy Nasdaq OMXApr 18, 2016, 12:00 PM UTC
BusinessThe Center's Publications Now Available as Healthcare Podcast EpisodesBy Nasdaq OMXApr 18, 2016, 11:36 AM UTC
BusinessClaire's Place Foundation Elects Laura McHolm as New Chairman of the BoardBy Nasdaq OMXApr 18, 2016, 7:25 AM UTC
BusinessMerus to Present Interim Clinical Data from Ongoing Phase 1/2 Clinical Trial of its Lead Bispecific Antibody Candidate, MCLA-128, at the American Association for Cancer Research 2016 Annual MeetingBy Nasdaq OMXApr 15, 2016, 9:06 PM UTC
BusinessAgile Therapeutics to Present at Women’s Health 2016: The 24th Annual CongressBy Nasdaq OMXApr 15, 2016, 12:00 PM UTC
BusinessNewLink Genetics Receives $2.8 Million Award from DTRA to Develop a Multivalent Filovirus VaccineBy Nasdaq OMXApr 15, 2016, 11:00 AM UTC
